Angiotensin II receptor blockers (ARBs) are the antihypertensive drugs associated with side effects, majorly like cough and electrolyte disturbance. Azilsartan is a newly marketed ARB in India, not even having well established adverse effects profile. Here we present a 58-year-old female who was admitted to the emergency department showing signs and symptoms of delirium, disorientation and vomiting for four days. The patient is known to have coronary artery disease (CAD) for that she underwent coronary artery bypass grafting (CABG). She was recently started on azilsartan for her chronic hypertension along with other drugs. The presence of electrolyte imbalance in laboratory reports and current symptoms suggested of azilsartan induced encephalopathy. The patient was recovered after discontinuation of azilsartan. This case enlightens the clinical characteristics, possible mechanism and treatment strategy opted to correct the condition.
Key words: Angiotensin II receptor blocker, Hyperkalemia, Hyponatremia, Hypertension, Renin-angiotensin-aldosterone-system
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
